Postprandial lipemia detects the effect of soy protein on cardiovascular disease risk compared with the fasting lipid profile.
Studies examining the effect of soy protein on cardiovascular disease (CVD) risk factors have not taken advantage of the postprandial state as an adjunct to the fasting lipid profile. The American Heart Association has acknowledged the efficacy of soy protein in reducing CVD risk factors to be limited. We hypothesized that the postprandial state would be more sensitive to any favorable changes associated with consuming soy protein compared with the fasting lipid profile. Furthermore, the presence of isoflavones in soy would enhance this effect. Thirty sedentary males aged 18-30 years were randomly assigned to milk protein (Milk), isoflavone-poor soy (Soy-), or isoflavone-rich soy (Soy+). Usual diets were supplemented with 25 g/day of protein for 28 days. Serum samples were collected before and after supplementation in a fasted state and postprandially at 30, 60, 120, 240, and 360 min after a high-fat, 1,000 kcal shake. Triacylglycerol (TAG), total cholesterol, non-esterified fatty acids, apolipoproteins B-100 and A-I and glucose concentrations were quantified. Fasting concentrations were not different after any protein supplementation. Postprandial TAG and TAG AUC increased after Soy-consumption supporting the postprandial state as a more sensitive indicator of soy ingestion effects on CVD risk factors compared with the fasting lipid profile. Furthermore, the absence of isoflavones in soy protein may have deleterious consequences on purported cardio-protective effects.
Santo
Antonio S
AS
Department of Kinesiology and Nutrition Sciences, University of Nevada, Las Vegas School of Allied Health Sciences, 4505 S. Maryland Parkway, Las Vegas, NV 89154-3034, USA. assanto@gmail.com
Santo
Ariana M
AM
Browne
Richard W
RW
Burton
Harold
H
Leddy
John J
JJ
Horvath
Steven M
SM
Horvath
Peter J
PJ
D000293:Adolescent; D000328:Adult; D002318:Cardiovascular Diseases / Q000453:epidemiology* / Q000517:prevention & control; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D004311:Double-Blind Method; D005215:Fasting; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood*; D007529:Isoflavones / Q000494:pharmacology; D050356:Lipid Metabolism; D008055:Lipids / Q000097:blood*; D008297:Male; D019518:Postprandial Period / Q000502:physiology*; D012307:Risk Factors; D030262:Soybean Proteins / Q000494:pharmacology*; D014280:Triglycerides / Q000097:blood
D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D007529:Isoflavones; D008055:Lipids; D030262:Soybean Proteins; D014280:Triglycerides